companydata.dkcompanydata.dk

Pharmaway Invest ApS: Financial statements 2020

CVR: 38585126

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

Pharmaway Invest ApS (CVR 38585126) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -23,125 and a net result of DKK -25,399 compared with DKK -14,676 the year before. Equity in the 2020 report amounted to DKK 36,089,218. The solvency ratio was 99.5%.

Gross Profit
DKK -23,125
Profit/Loss
DKK -25,399
Equity
DKK 36,089,218
Total Assets
DKK 36,266,184

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020--23K-25K36.1M-
2019--13K-15K33.8M-
2018--4K-6K33.9M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Pharmaway Invest ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Pharmaway Invest ApS: The 2019 annual report is outMay 30, 2020

Pharmaway Invest ApS has published its annual report for 2019. Gross profit came to DKK -12,500, and the net result was DKK -14,676.

About Pharmaway Invest ApS

Pharmaway Invest ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Niels Ebbe Ebbesen. The company's owners include Ebbelykke ApS, Hundekurven ApS and Ebfos Family Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -23,125 and a net result of DKK -43,449,506 compared with DKK -38,583 the year before. Equity in the 2025 report amounted to DKK 4,538,851.

Source: annual report 2025, Danish Business Authority

Other financial years